MIT and participating organizations aimed to create a mechanistic model of vaccine production for the development of the continuous operation of an upstream cell culture process to produce a model vaccine. This approach could be generalizable to a variety of vaccine production systems based upon the characteristics of the host cell line being used and the vaccine being produced.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
Massachusetts Institute of Technology